Doesn't matter. How long will it be till this company is, if ever, at that point? Could be 10 years or longer. In the meantime, they will repeatedly dilute the shares outstanding and won't be contributing to adding shareholder value. An early stage biotech like this is probably the worst company you could invest your money in.